$566,898
+12.2%
Vice President, Clinical Innovation and President
2024
$535k related
--
$33k other
--
Vice President, Clinical Innovation and President at Mercy Research
Fiscal year ended June 30, 2024. Published on January 25, 2026.
Total compensation
Broyles M.D. Damon has been listed as an employee of Mercy Research in Form 990 filings since fiscal year 2023. Total compensation for Broyles M.D. Damon has increased by 12.2% from 2023 to 2024.